ArticlePloS one2022

SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.

Rie Matsushima-Nishiwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.